Polymer Capital Management HK LTD Takes Position in SPDR S&P Biotech ETF $XBI

Polymer Capital Management HK LTD bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 48,200 shares of the exchange traded fund’s stock, valued at approximately $5,877,000. SPDR S&P Biotech ETF comprises 0.8% of Polymer Capital Management HK LTD’s portfolio, making the stock its 25th biggest holding. Polymer Capital Management HK LTD owned approximately 0.07% of SPDR S&P Biotech ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of XBI. AQR Capital Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after purchasing an additional 2,167 shares during the last quarter. Marshall Wace LLP raised its stake in shares of SPDR S&P Biotech ETF by 102.3% in the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after acquiring an additional 179,029 shares during the period. The Manufacturers Life Insurance Company purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth $260,000. Ameriprise Financial Inc. increased its stake in SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.7% during the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after buying an additional 193 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $133.79 on Friday. The firm has a market cap of $8.54 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 1-year low of $80.90 and a 1-year high of $139.19. The firm has a fifty day moving average of $132.63 and a two-hundred day moving average of $127.12.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.